BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹68 Cr | ₹48 Cr | ₹46 Cr | ₹35 Cr | ₹5.91 Cr |
What is the latest Total Non-Current Assets ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹5.91 Cr |
How is Total Non-Current Assets of BALAXI PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹68 Cr | 40.29 | |
| Mar2024 | ₹48 Cr | 4.36 | |
| Mar2023 | ₹46 Cr | 30.14 | |
| Mar2022 | ₹35 Cr | 500.24 | |
| Mar2021 | ₹5.91 Cr | - | |
Compare Total Non-Current Assets of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹120.8 Cr | 32.8% | 15.9% | -67.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹245,965.0 Cr | 4.4% | -10.4% | -19.9% | Stock Analytics | |
| REDINGTON | ₹16,206.2 Cr | 3.2% | -21.1% | -17.7% | Stock Analytics | |
| HONASA CONSUMER | ₹9,909.1 Cr | 2.2% | 4% | 30% | Stock Analytics | |
| MMTC | ₹8,457.0 Cr | 2.2% | -3.8% | 2.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,267.9 Cr | 11.8% | -4.1% | 12.7% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 32.8% |
15.9% |
-67.4% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses